Summit Therapeutics Inc. Form SC 13D: Beneficial ownership report (active)
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-09-13: Form SC 13D/A; Description SC 13D/A; Document d868966dsc13da.htm.
- 2023-03-13: Form SC 13D/A; Description AMENDMENT TO FORM SC 13D; Document summit-sc13da_030923.htm.
- 2023-02-16: Form SC 13D/A; Description SC 13D/A; Document tm237077d1_sc13da.htm.
- 2022-12-09: Form SC 13D/A; Description AMENDMENT TO FORM SC 13D; Document summit-sc13da_120622.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-09-13 | SC 13D/A | SC 13D/A | d868966dsc13da.htm | |
| 2023-03-13 | SC 13D/A | AMENDMENT TO FORM SC 13D | summit-sc13da_030923.htm | |
| 2023-02-16 | SC 13D/A | SC 13D/A | tm237077d1_sc13da.htm | |
| 2022-12-09 | SC 13D/A | AMENDMENT TO FORM SC 13D | summit-sc13da_120622.htm | |
| 2022-08-18 | SC 13D/A | AMENDMENT TO FORM SC 13D | summit-sc13da_081622.htm | |
| 2021-05-14 | SC 13D/A | Beneficial ownership report (active) | sc13da512566001_05142021.htm | |
| 2021-04-22 | SC 13D/A | Beneficial ownership report (active) | sc13da412566002_04222021.htm | |
| 2021-03-26 | SC 13D/A | Beneficial ownership report (active) | sc13da312566002_03262021.htm | |
| 2020-11-25 | SC 13D/A | Beneficial ownership report (active) | sc13da212566zan_11242020.htm | |
| 2020-11-10 | SC 13D/A | Beneficial ownership report (active) | sc13da112566zan_11102020.htm | |
| 2020-11-10 | SC 13D/A | Beneficial ownership report (active) | sc13da212566001_11102020.htm | |
| 2020-10-07 | SC 13D/A | Beneficial ownership report (active) | sc13da112566dug_10062020.htm | |
| 2020-09-28 | SC 13D | Beneficial ownership report (active) | sc13d12566zan_09282020.htm | |
| 2020-09-28 | SC 13D | Beneficial ownership report (active) | sc13d12566dug_09282020.htm | |
| 2020-06-17 | SC 13D/A | Beneficial ownership report (active) | d8559289_13d-a.htm | |
| 2020-05-15 | SC 13D/A | Beneficial ownership report (active) | d8535963_13d-a.htm | |
| 2020-03-26 | SC 13D/A | Beneficial ownership report (active) | d8502450_13d-a.htm | |
| 2020-01-23 | SC 13D | Beneficial ownership report (active) | sc13d11732sum_01232020.htm | |
| 2020-01-16 | SC 13D/A | Beneficial ownership report (active) | sc13da306922012_01162020.htm | |
| 2019-12-27 | SC 13D/A | Beneficial ownership report (active) | sc13da206922012_12272019.htm | |
| 2019-12-10 | SC 13D/A | Beneficial ownership report (active) | sc13da106922012_12102019.htm | |
| 2019-01-22 | SC 13D | THE SCHEDULE 13D | sc13d06922010_01222019.htm | |
| 2019-01-11 | SC 13D/A | Beneficial ownership report (active) | d8121757_13da.htm | |
| 2018-01-30 | SC 13D/A | Beneficial ownership report (active) | d7802705_13d-a.htm | |
| 2017-09-20 | SC 13D/A | Beneficial ownership report (active) | d7657444_13-da.htm | |
| 2015-03-26 | SC 13D/A | Beneficial ownership report (active) | d6450089_13d-a.htm | |
| 2015-03-16 | SC 13D | Beneficial ownership report (active) | d6409008_13-d.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |